168 related articles for article (PubMed ID: 17154515)
1. trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist.
Cueva JP; Giorgioni G; Grubbs RA; Chemel BR; Watts VJ; Nichols DE
J Med Chem; 2006 Nov; 49(23):6848-57. PubMed ID: 17154515
[TBL] [Abstract][Full Text] [Related]
2. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE
J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526
[TBL] [Abstract][Full Text] [Related]
3. Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine.
Negash K; Nichols DE; Watts VJ; Mailman RB
J Med Chem; 1997 Jul; 40(14):2140-7. PubMed ID: 9216832
[TBL] [Abstract][Full Text] [Related]
4. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
Mottola DM; Brewster WK; Cook LL; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 1992 Jul; 262(1):383-93. PubMed ID: 1352553
[TBL] [Abstract][Full Text] [Related]
5. 8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms.
Grubbs RA; Lewis MM; Owens-Vance C; Gay EA; Jassen AK; Mailman RB; Nichols DE
Bioorg Med Chem; 2004 Mar; 12(6):1403-12. PubMed ID: 15018913
[TBL] [Abstract][Full Text] [Related]
6. Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.
Mottola DM; Laiter S; Watts VJ; Tropsha A; Wyrick SD; Nichols DE; Mailman RB
J Med Chem; 1996 Jan; 39(1):285-96. PubMed ID: 8568818
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist.
Knoerzer TA; Nichols DE; Brewster WK; Watts VJ; Mottola D; Mailman RB
J Med Chem; 1994 Jul; 37(15):2453-60. PubMed ID: 7914538
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands.
Qandil AM; Lewis MM; Jassen A; Leonard SK; Mailman RB; Nichols DE
Bioorg Med Chem; 2003 Apr; 11(7):1451-64. PubMed ID: 12628671
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and dopamine receptor affinities of N-alkyl-11-hydroxy-2-methoxynoraporphines: N-alkyl substituents determine D1 versus D2 receptor selectivity.
Si YG; Gardner MP; Tarazi FI; Baldessarini RJ; Neumeyer JL
J Med Chem; 2008 Feb; 51(4):983-7. PubMed ID: 18251489
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors.
Knoerzer TA; Watts VJ; Nichols DE; Mailman RB
J Med Chem; 1995 Aug; 38(16):3062-70. PubMed ID: 7636869
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cis- and trans-9- and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as structurally rigid, selective D1 dopamine receptor ligands.
Brewster WK; Nichols DE; Watts VJ; Riggs RM; Mottola D; Mailman RB
J Med Chem; 1995 Jan; 38(2):318-27. PubMed ID: 7830274
[TBL] [Abstract][Full Text] [Related]
12. (+)-Dinapsoline: an efficient synthesis and pharmacological profile of a novel dopamine agonist.
Sit SY; Xie K; Jacutin-Porte S; Taber MT; Gulwadi AG; Korpinen CD; Burris KD; Molski TF; Ryan E; Xu C; Wong H; Zhu J; Krishnananthan S; Gao Q; Verdoorn T; Johnson G
J Med Chem; 2002 Aug; 45(17):3660-8. PubMed ID: 12166939
[TBL] [Abstract][Full Text] [Related]
13. Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines.
Cueva JP; Chemel BR; Juncosa JI; Lill MA; Watts VJ; Nichols DE
Eur J Med Chem; 2012 Feb; 48():97-107. PubMed ID: 22204903
[TBL] [Abstract][Full Text] [Related]
14. Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands.
Claudi F; Di Stefano A; Napolitani F; Cingolani GM; Giorgioni G; Fontenla JA; Montenegro GY; Rivas ME; Rosa E; Michelotto B; Orlando G; Brunetti L
J Med Chem; 2000 Feb; 43(4):599-608. PubMed ID: 10691686
[TBL] [Abstract][Full Text] [Related]
15. trans-10,11-dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine: a highly potent selective dopamine D1 full agonist.
Brewster WK; Nichols DE; Riggs RM; Mottola DM; Lovenberg TW; Lewis MH; Mailman RB
J Med Chem; 1990 Jun; 33(6):1756-64. PubMed ID: 1971308
[TBL] [Abstract][Full Text] [Related]
16. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
Shuto T; Seeman P; Kuroiwa M; Nishi A
Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
[TBL] [Abstract][Full Text] [Related]
17. Facile synthesis of octahydrobenzo[h]isoquinolines: novel and highly potent D1 dopamine agonists.
Bonner LA; Chemel BR; Watts VJ; Nichols DE
Bioorg Med Chem; 2010 Sep; 18(18):6763-70. PubMed ID: 20709559
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane.
Doll MK; Nichols DE; Kilts JD; Prioleau C; Lawler CP; Lewis MM; Mailman RB
J Med Chem; 1999 Mar; 42(5):935-40. PubMed ID: 10072690
[TBL] [Abstract][Full Text] [Related]
19. Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists.
Ryman-Rasmussen JP; Nichols DE; Mailman RB
Mol Pharmacol; 2005 Oct; 68(4):1039-48. PubMed ID: 15985612
[TBL] [Abstract][Full Text] [Related]
20. Preparation and pharmacological characterization of trans-2-amino-5(6)-fluoro-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes as D2-like dopamine receptor agonists.
Di Stefano A; Sozio P; Cacciatore I; Cocco A; Giorgioni G; Costa B; Montali M; Lucacchini A; Martini C; Spoto G; Di Pietrantonio F; Di Matteo E; Pinnen F
J Med Chem; 2005 Apr; 48(7):2646-54. PubMed ID: 15801855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
